Top line stable.
+4.9% YoY versus +6.1% prior. 3y CAGR +5.3%.
+4.9%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $14.5B
Live price unavailable
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Concerns — Jazz Pharmaceuticals plc's 0.7% ROE is below sector median.
Financial story
Concerns — Jazz Pharmaceuticals plc's 0.7% ROE and 1.62 debt-to-equity warrant a closer look at the underlying business.
Bottom line: JAZZ currently has no legendary investor models qualifying — see /stock/JAZZ/valuation for the per-model breakdown, but earns a C sector grade (58/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
+4.9% YoY versus +6.1% prior. 3y CAGR +5.3%.
+4.9%Net margin −8.3% versus 13.8% prior (−22.1pp). Operating 5.3%.
−8.3%P/E 2168.8x — 11019% above the 5y median of 19.5x. Forward 9.4x hints at EPS expansion next year.
2168.8xJAZZ's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
JAZZ is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate JAZZ a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Jazz Pharmaceuticals plc's fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
JAZZ trades at 2052.6x earnings. Sector context and per-investor signals are in the valuation tab.
JAZZ and SMMT differ on P/E, ROE, and revenue growth. See the full JAZZ vs SMMT compare matrix.
How does JAZZ compare?
See exactly where JAZZ ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingJAZZ sits at #22 in Healthcare with a C grade (58/100).